Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23414321 | 0.82 | — | — | |
| SCHEMBL23414319 | 0.82 | — | — | |
| SCHEMBL26798076 | 0.81 | — | — | |
| SCHEMBL26797978 | 0.79 | — | — | |
| SCHEMBL26798209 | 0.78 | — | — | |
| SCHEMBL26798028 | 0.77 | TSHR (0.32) | — | |
| SCHEMBL26798114 | 0.73 | — | — | |
| SCHEMBL26798256 | 0.70 | — | — | |
| SCHEMBL5889420 | 0.68 | CYP3A4 (0.33) | — | |
| SCHEMBL9845185 | 0.68 | CYP3A4 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112457181-A | Synthesis method of D-calcium pantothenate | 黄冈美丰化工科技有限公司 | 2021-03-09 | — | — | CN | claimed |
| CN-117700380-A | Synthesis method of DL-pantothenic acid lactone | 重庆市化工研究院有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-219815355-U | Extraction kettle for refining 4-chloro-3 ',4' -dimethoxy benzophenone | 甘肃汉隆化工有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-115299595-A | Coix seed and vinasse composite enzyme rich in gamma-aminobutyric acid and preparation method thereof | 贵州庄稼汉薏米产业开发有限公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-114107114-A | Preparation method of immobilized neurospora | 湖北楚维药业有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-213285735-U | Pantolactone extraction kettle | 浙江佳泰科技有限公司 | 2021-05-28 | — | — | CN | disclosed |
| CN-213285735-U | Pantolactone extraction kettle | 浙江佳泰科技有限公司 | 2021-05-28 | — | — | CN | disclosed |
| CN-112457181-A | Synthesis method of D-calcium pantothenate | 黄冈美丰化工科技有限公司 | 2021-03-09 | — | — | CN | disclosed |
| CN-111117897-A | Fusarium moniliforme JHpharm 2-1 for high-yield D-pantolactone hydrolase and fermentation method thereof | 南京金浩医药科技有限公司 | 2020-05-08 | — | — | CN | disclosed |
| CN-106535864-A | Composition for preparing carbon dioxide formulation for external use, method for producing same, method for evaluating same, and carbon dioxide formulation for external use | 株式会社IBTJ | 2017-03-22 | — | — | CN | disclosed |
| CN-102755882-A | Application of Beta-cyclodextrin derivatives in preparing gas chromatography chiral stationary phases | UNIV CHINA AGRICULTURAL | 2012-10-31 | — | — | CN | disclosed |
| WO-2012143576-A2 | COMPOUNDS FOR PREVENTING, REDUCING AND/OR ALLEVIATING ITCHY SKIN CONDITION(S) | SYMRISE AG (DE) | 2012-10-26 | — | — | WO | disclosed |
| US-8241681-B2 | Synergistic mixtures of bisabolol and ginger extract | SYMRISE AG (DE) | 2012-08-14 | — | — | US | disclosed |
| US-20120121737-A1 | COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT | SYMRISE AG (DE) | 2012-05-17 | — | — | US | disclosed |
| EP-2416766-A2 | COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT | Symrise AG (DE) | 2012-02-15 | — | — | EP | disclosed |
| US-20090220625-A1 | SYNERGISTIC MIXTURES OF BISABOLOL AND GINGER EXTRACT | SYMRISE AG (DE) | 2009-09-03 | — | — | US | disclosed |
| US-20090208434-A1 | 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use in cosmetic and pharmaceutical preparations | SYMRISE GMBH & CO. KG (DE) | 2009-08-20 | — | — | US | disclosed |
| WO-2009087242-A2 | COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT | SYMRISE GMBH & CO. KG (DE) | 2009-07-16 | — | — | WO | disclosed |
| EP-1937366-A1 | SYNERGISTIC MIXTURES OF BISABOLOL AND GINGER EXTRACT | Symrise GmbH & Co. KG (DE) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007042472-A1 | SYNERGISTIC MIXTURES OF BISABOLOL AND GINGER EXTRACT | SYMRISE GMBH & CO. KG (DE) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090208434-A1 | 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use in cosmetic and pharmaceutical preparations | CYP8B1, FOXK1, CYP1B1 | CRBN 4116/4885 |
| US-20120121737-A1 | COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT | TERT, CUTA, TRPA1 | CRBN 3973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.